MedPath

Newborns Supplemented With Gentle-UHT Donor Milk

Not Applicable
Completed
Conditions
Breast Milk Expression
Newborns
Interventions
Other: Gentle-UHT donor human milk supplementation
Registration Number
NCT04492579
Lead Sponsor
LactaLogics, Inc
Brief Summary

This study evaluates the effects of providing breastfeeding mothers with Gentle-UHT donor human milk (GHM) after discharge to bridge the gap during delayed onset lactation, to support an exclusive human milk diet and continued breastfeeding through the infant's first week of life. The investigators aim to determine the safety of GHM, and if GHM provided to breastfeeding mothers of outpatient babies with early weight loss will ensure babies adequately gain weight according to age-matched controls.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
31
Inclusion Criteria
  • Gestational age >36 weeks
  • Exclusively fed human milk
  • Age <96 hours (4 days)
Exclusion Criteria
  • Previous admittance to the neonatal intensive care unit
  • Supplementation of any formula

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Supplementation of Gentle-UHT donor milkGentle-UHT donor human milk supplementationSupplementation of Gentle-UHT donor milk in addition to mother's own milk, as recommended by the health care providers.
Primary Outcome Measures
NameTimeMethod
Weight gain8-9 days of life

Average weights compared to WHO data

Secondary Outcome Measures
NameTimeMethod
Exclusive human milk diet8-9 days of life

Rates of infants still on an exclusive human milk diet

Trial Locations

Locations (1)

LactaLogics, Inc.

🇺🇸

Port Saint Lucie, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath